Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$5.95
-3.7%
$5.31
$4.22
$8.90
$68.15M0.235,836 shs2,834 shs
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
$5.26
-4.0%
$5.96
$3.50
$7.40
$25.67M0.061,497 shs641 shs
Mural Oncology plc stock logo
MURA
Mural Oncology
$3.83
+0.3%
$4.49
$3.23
$17.00
$64.82MN/A206,440 shs101,024 shs
XpresSpa Group, Inc. stock logo
XSPA
XpresSpa Group
$0.84
$0.63
$2.19
$61.75M2.12988,656 shs171,700 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
0.00%+1.02%+13.12%+2.59%-13.77%
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
0.00%-11.60%-15.16%-11.89%-4.54%
Mural Oncology plc stock logo
MURA
Mural Oncology
0.00%+6.98%-16.74%-14.89%+382,999,900.00%
XpresSpa Group, Inc. stock logo
XSPA
XpresSpa Group
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
1.8461 of 5 stars
3.55.00.00.00.60.00.6
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Mural Oncology plc stock logo
MURA
Mural Oncology
2.1658 of 5 stars
3.51.00.00.02.51.71.3
XpresSpa Group, Inc. stock logo
XSPA
XpresSpa Group
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
3.00
Buy$11.0084.87% Upside
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
N/AN/AN/AN/A
Mural Oncology plc stock logo
MURA
Mural Oncology
3.00
Buy$13.00239.43% Upside
XpresSpa Group, Inc. stock logo
XSPA
XpresSpa Group
N/AN/AN/AN/A

Current Analyst Ratings

Latest XSPA, MRM, CLGN, and MURA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/5/2024
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00
4/4/2024
Mural Oncology plc stock logo
MURA
Mural Oncology
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$13.00
(Data available from 5/5/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$10.96M6.22N/AN/A$2.47 per share2.41
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
$53.25M0.48$0.50 per share10.46($0.09) per share-58.44
Mural Oncology plc stock logo
MURA
Mural Oncology
N/AN/AN/AN/A$15.81 per shareN/A
XpresSpa Group, Inc. stock logo
XSPA
XpresSpa Group
$73.73M0.00N/A8.87$0.95 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
-$7.02M-$0.64N/AN/AN/A-64.05%-22.17%-18.84%5/22/2024 (Estimated)
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
$1.15MN/A0.00N/AN/AN/AN/A5/29/2024 (Estimated)
Mural Oncology plc stock logo
MURA
Mural Oncology
-$207.45MN/A0.00N/AN/AN/AN/AN/A6/25/2024 (Estimated)
XpresSpa Group, Inc. stock logo
XSPA
XpresSpa Group
$3.35M-$0.04N/AN/AN/A-3.55%-3.58%-2.82%N/A

Latest XSPA, MRM, CLGN, and MURA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/4/2024Q4 2023
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/A-$0.42-$0.42-$0.42N/A$0.30 million
3/26/2024Q4 2023
Mural Oncology plc stock logo
MURA
Mural Oncology
N/A-$3.57-$3.57-$3.57N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/AN/AN/AN/AN/A
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
N/AN/AN/AN/AN/A
Mural Oncology plc stock logo
MURA
Mural Oncology
N/AN/AN/AN/AN/A
XpresSpa Group, Inc. stock logo
XSPA
XpresSpa Group
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/A
8.62
8.40
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
N/AN/AN/A
Mural Oncology plc stock logo
MURA
Mural Oncology
N/A
9.56
9.56
XpresSpa Group, Inc. stock logo
XSPA
XpresSpa Group
N/A
5.93
5.84

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
21.69%
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
N/A
Mural Oncology plc stock logo
MURA
Mural Oncology
80.21%
XpresSpa Group, Inc. stock logo
XSPA
XpresSpa Group
13.35%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
7311.45 million10.35 millionOptionable
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
4344.88 million2.92 millionNot Optionable
Mural Oncology plc stock logo
MURA
Mural Oncology
11716.92 million16.91 millionNo Data
XpresSpa Group, Inc. stock logo
XSPA
XpresSpa Group
36394.28 million92.11 millionOptionable

XSPA, MRM, CLGN, and MURA Headlines

SourceHeadline
XpresSpa Group (NASDAQ: XSPA)XpresSpa Group (NASDAQ: XSPA)
fool.com - August 16 at 4:32 AM
XWELL to Bring Robotic Manicures to US Airports Through New Partnership with ClockworkXWELL to Bring Robotic Manicures to US Airports Through New Partnership with Clockwork
finance.yahoo.com - November 7 at 10:18 AM
XWELL Celebrates Opening of New Treat Location at Salt Lake City International AirportXWELL Celebrates Opening of New Treat Location at Salt Lake City International Airport
finance.yahoo.com - November 2 at 4:17 PM
XpresSpa Group, Inc.: XpresSpa Group Announces New Corporate IdentityXpresSpa Group, Inc.: XpresSpa Group Announces New Corporate Identity
finanznachrichten.de - October 25 at 2:08 PM
XpresSpa Group Announces New Corporate IdentityXpresSpa Group Announces New Corporate Identity
finance.yahoo.com - October 24 at 9:38 AM
XpresSpa Pivots Back From Covid Testing With A More Balanced Retail VisionXpresSpa Pivots Back From Covid Testing With A More Balanced Retail Vision
forbes.com - September 30 at 8:17 AM
XSPA XpresSpa Group, Inc.XSPA XpresSpa Group, Inc.
seekingalpha.com - September 27 at 11:06 PM
XpresSpa Group Expands Retail Products for Women, Underscoring Company’s Commitment to Support Women’s Health and WellnessXpresSpa Group Expands Retail Products for Women, Underscoring Company’s Commitment to Support Women’s Health and Wellness
finance.yahoo.com - September 21 at 9:13 AM
XpresSpa Group Inc. Reports Q2 Revenue of $13.6M, Loss of $7.9MXpresSpa Group Inc. Reports Q2 Revenue of $13.6M, Loss of $7.9M
uk.investing.com - August 16 at 6:29 PM
XpresSpa Group, Inc. (XSPA) CEO Scott Milford on Q2 2022 Results - Earnings Call TranscriptXpresSpa Group, Inc. (XSPA) CEO Scott Milford on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 15 at 8:52 PM
An Airport Spa And Biosecurity Co. Act As "Surveillance" In US Airports As Part Of $60M CDC "Early Warning" Contract For SARS-CoV-2An Airport Spa And Biosecurity Co. Act As "Surveillance" In US Airports As Part Of $60M CDC "Early Warning" Contract For SARS-CoV-2
finance.yahoo.com - August 15 at 8:52 PM
XpresSpa Group Reports Second Quarter 2022 ResultsXpresSpa Group Reports Second Quarter 2022 Results
finance.yahoo.com - August 15 at 8:52 PM
XpresSpa Group, Inc. (XSPA) Reports Q2 Loss, Tops Revenue EstimatesXpresSpa Group, Inc. (XSPA) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 15 at 8:52 PM
XpresSpa Group Announces the Re-Opening of XpresSpa(TM) Location at John F. Kennedy International Airports Terminal 4XpresSpa Group Announces the Re-Opening of XpresSpa(TM) Location at John F. Kennedy International Airport's Terminal 4
stockhouse.com - August 14 at 9:18 PM
XpresSpa Group Re-Opens Its JFK Terminal 4 LocationXpresSpa Group Re-Opens Its JFK Terminal 4 Location
metroairportnews.com - August 12 at 6:07 PM
XpresSpa Group Announces the Re-Opening of XpresSpa™ Location at  John F. Kennedy International Airport’s Terminal 4XpresSpa Group Announces the Re-Opening of XpresSpa™ Location at John F. Kennedy International Airport’s Terminal 4
finance.yahoo.com - August 12 at 1:07 PM
XpresSpa Group Announces the Re-Opening of XpresSpa™ Location at John F. Kennedy International Airport’s Terminal 4XpresSpa Group Announces the Re-Opening of XpresSpa™ Location at John F. Kennedy International Airport’s Terminal 4
nz.finance.yahoo.com - August 12 at 8:06 AM
XpresSpa Group to Announce Second Quarter 2022 Financial Results on Monday, August 15XpresSpa Group to Announce Second Quarter 2022 Financial Results on Monday, August 15
finance.yahoo.com - August 10 at 7:31 PM
XpresSpa Ramps Up International Expansion EffortsXpresSpa Ramps Up International Expansion Efforts
finance.yahoo.com - July 11 at 8:44 PM
XpresSpa Group Expanding to Istanbul Airport in SeptemberXpresSpa Group Expanding to Istanbul Airport in September
marketwatch.com - July 11 at 3:43 PM
XpresSpa Group Announces Plan for Expansion InternationallyXpresSpa Group Announces Plan for Expansion Internationally
finance.yahoo.com - July 11 at 3:43 PM
Looking Into XpresSpa Groups Return On Capital EmployedLooking Into XpresSpa Group's Return On Capital Employed
msn.com - June 22 at 5:26 PM
XpresSpa announces separation of service with CFO James BerryXpresSpa announces separation of service with CFO James Berry
seekingalpha.com - June 16 at 1:02 PM
XpresSpa Group Announces the Separation of Service of Chief Financial Officer James BerryXpresSpa Group Announces the Separation of Service of Chief Financial Officer James Berry
finance.yahoo.com - June 14 at 6:12 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

CollPlant Biotechnologies logo

CollPlant Biotechnologies

NASDAQ:CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; Tel Aviv University; Sheba Medical Center; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
MEDIROM Healthcare Technologies logo

MEDIROM Healthcare Technologies

NYSE:MRM
MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, an on-demand health monitoring smartphone application and MOTHER Bracelet for fitness applications; and preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Mural Oncology logo

Mural Oncology

NASDAQ:MURA
Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.
XpresSpa Group logo

XpresSpa Group

NASDAQ:XSPA
XpresSpa Group, Inc., a health and wellness services company, provides spa services at airports. It operates through three segments: XpresSpa, XpresTest, and Treat. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018. XpresSpa Group, Inc. is headquartered in New York, New York.